FDA announces new data points to aid generic drug developers
The FDA has released new data points which increase transparency for generic-drug competitors.
List view / Grid view
The FDA has released new data points which increase transparency for generic-drug competitors.
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
The CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.
A study has predicted that the global biopharmaceutical contract manufacturing market will grow by 10.6 percent from 2017 to 2027.
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
A new report predicts that the packaging and labelling industry for pharmaceutical products will increase by 5.3 percent.
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.